Search clinical trials for: Interchangeability between marketed generic formulations

Total 7868 results

King Faisal Specialist Hospital & Research Center
Saudi National Comprehensive Plan for Science & Technology

Completed

Generic Formulations of Commonly-used Oral Drugs in Saudi Arabia:Interchangeability & Post-marketing Quality

Generic Drug Quality | Generic Formulation Interchangeability

Saudi Arabia
McNeil AB

Completed

To Test Bioequivalence Between Two Tablet Formulations in the Treatment of Allergy

Allergy

Canada
AstraZeneca

Recruiting

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oral AZD6793 in Healthy Subjects and to Assess the Relative Oral Bioavailability Between Two Formulations. The Study Will Also Assess the Food Effect on the PK of AZD6793 Compared to Fasting State

Inflammatory Diseases

United Kingdom
Zhejiang Teruisi Pharmaceutical Inc.

Not yet recruiting

A Study Assessing the Interchangeability Between TRS003 and Bevacizumab® For CRC (CRC)

Metastatic Colorectal Cancer (CRC)
University Hospital, Brest

Recruiting

General Practitioners and Participation Rate in ColoRectal Cancer Screening (AMDepCCR)

Colorectal Cancer

France
Cenk Gacemer

Completed

Comparison Of The Analgesic Efficacy Of IPACK (Interspace Between The Popliteal Artery And Capsule Of The Posterior Knee) Block Alone And IPACK Block Combined With Genicular Block In Patients Planned For Total Knee Arthroplasty

Anesthesia | Orthopedic Disorder | Knee Arthropathy | Pain, Joint

Turkey
Padagis LLC

Completed

Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations

Acne Vulgaris
Indivior Inc.
Reckitt Benckiser LLC

Completed

Study of Two Formulations of Buprenorphine HCl in Opioid-dependent Subjects on Buprenorphine Maintenance Therapy (Study P04451) (COMPLETED)

Opioid Dependency
Bristol-Myers Squibb

Completed

A Study to Compare the Drug Levels of Atazanavir and Cobicistat Between the Coadministration of Age-Appropriate Mini-Tablet Formulations and the Coadministration of the Individual Reference Products in Healthy Adults Under Fed Conditions

Healthy Participants

United States
Yuhan Corporation

Completed

Clinical Trial to Assess Bioequivalence of Lazertinib Between Two Formulations in Healthy Volunteers.

Healthy Adult Volunteers

Korea, Republic of
Seoul National University Hospital

Completed

Switchability Study Between Brand and Generic Topiramate

Epilepsy

Korea, Republic of
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Relative Bioavailability Study Between Two Formulations Of Sildenafil Citrate (A1481272)

Erectile Dysfunction

Brazil
Radboud University Medical Center

Completed

Pharmacokinetic Study of Two Generic Co-formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF) (SURF)

HIV Infections

Netherlands
The HIV Netherlands Australia Thailand Research...
Mylan Laboratories

Completed

Therapeutic Drug Monitoring (TDM) in Generic Tenofovir/Lamivudine/Efavirenz

HIV

Thailand
Food and Drug Administration (FDA)
Algorithme Pharma Inc; Vince & Associates Clinical Research, Inc.

Completed

A Bioavailability Crossover Study of Two Formulations of Lamotrigine Extended Release Tablets in Healthy Subjects

Healthy

United States
Akebia Therapeutics

Completed

A Study in Evaluating Bioequivalence Between Test and Reference Formulations of Vadadustat Tablets in Healthy Adults

Healthy

United States
National Institute of Pediatrics, Mexico
Merck Sharp & Dohme LLC; Centro Nacional para la Salud de la Infancia y la...

Completed

Randomized, Controlled Single-blind Clinical Study to Assess Vaccine Interchangeability Between RV5 and RV1 Using Seven Combined Anti-rotavirus Prevention Programs

Rotavirus Vaccine

Mexico
Bundang CHA Hospital

Completed

Comparative Pharmacokinetic Study Between Two Extended-Release Cilostazol Formulations in Korea

Peripheral Artery Disease

Korea, Republic of
Bristol-Myers Squibb

Withdrawn

Evaluate the Bioavailability Between 2 BMS-986141 Formulations in Healthy Participants

Healthy
Adocia

Completed

A Trial to Investigate the Safety and the Pharmacokinetic, Pharmacodynamic Characteristics of Two BioChaperone® Glucagon Formulations Compared to Marketed GlucaGen® in Subjects With T1DM

Type 1 Diabetes Mellitus

Germany
AstraZeneca
Parexel

Completed

A Study to Assess Therapeutic Equivalence Between Test EMLA Patch With Marketed EMLA Patch in Healthy Subjects. (EMLA)

Pain

Germany
Mundipharma Research Limited

Completed

A Study of Whether 3 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication

Pain

United Kingdom
Eurofarma Laboratorios S.A.

Completed

Pharmacokinetics and Pharmacodynamics Comparison Study Between Two Pegfilgrastim Formulations

Healthy | Neutropenia

Brazil
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Bioequivalence of an Oral Suspension Formulation, an Oral Solution Formulation, and the Marketed Tablet Formulation of Levofloxacin in Healthy Subjects

Healthy
Federal University of São Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil (WARFA)

Atrial Fibrillation

Brazil
Ache Laboratorios Farmaceuticos S.A.

Withdrawn

Study Comparing 3 Formulations to Evaluate the Efficacy and Safety of the Inflammatory Symptoms of the Upper Respiratory Tract, in Children Between 2 and 6 Years Old

Common Cold

Brazil
Pfizer
Investigación Farmacológica y Biofarmacéutica

Withdrawn

Triazolam Trial In Healthy Subjects To Compare Bioavailability Between Formulations Of Triazolam To Determine Their Bioequivalence In Terms Of Rate And Magnitude Of Absorption

Healthy Volunteers
Boehringer Ingelheim

Completed

Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride

Healthy
Bial - Portela C S.A.

Completed

Relative Bioavailability and Bioequivalence Of Different Formulations of Opicapone in Healthy Volunteers

Parkinson
Universidade Federal de Pernambuco

Completed

Bioequivalence Study Between Lamivudine Formulations in the Form of Coated Tablet of 150 mg in Healthy Volunteers

HIV INFECTIONS
Novo Nordisk A/S

Completed

Bioequivalence Between Two Explorative Insulin Degludec Formulations and Between Two Explorative IDegAsp Formulations in Healthy Subjects

Healthy | Diabetes

Germany
Mundipharma Research Limited

Completed

A Study of Whether 2 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication

Pain

United Kingdom
Novo Nordisk A/S

Completed

A Comparison Between Two Formulations of NN5401 in Healthy Subjects

Healthy | Diabetes

United States
Merck Sharp & Dohme LLC

Completed

Bioequivalence of Two Formulations of Ondansetron in Healthy Adults (0869-106)

Chemotherapy-Induced Nausea and Vomiting
Farmoquimica S.A.
Pharmagenix Projetos em Medicina Farmacêutica Ltda.

Completed

A Comparative Study Between Two Formulations of the Ciprofloxacin Hydrochloride + Hydrocortisone Otic Suspension

Otitis Externa

Brazil
LEO Pharma

Completed

An Irritation Study With New Calcipotriol Ointment Formulations in Healthy Subjects

Irritation

France
GlaxoSmithKline

Completed

A Study to Compare to the Pharmacokinetic Profile of Two Paracetamol Formulations

Healthy Subjects

United States
GlaxoSmithKline

Completed

A Study to Compare Two Paracetamol Formulations.

Pain

United States
Bayer

Completed

Cross-over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel 1.5 mg (LEVEQ-3)

Contraceptives, Postcoital

Mexico
Novo Nordisk A/S

Completed

A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy Subjects

Healthy | Diabetes Mellitus, Type 2 | Diabetes

Germany
LEO Pharma

Completed

A Psoriasis Plaque Test Comparing Eight Different Formulations of Vitamin D Analogues for the Treatment of Psoriasis

Psoriasis Vulgaris

France
Blu Caribe

Completed

Bioequivalence Study Between Two Oral Formulations of Gemfibrozil Tablets

Bioavailability
Bayer

Completed

Cross -Over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel (LEVEQ-2)

Contraception | Contraception, Postcoital

Mexico
Bayer

Completed

Cross-over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel (LEVEQ-1)

Contraception | Contraception, Postcoital

Mexico
McNeil AB

Completed

Bioequivalence Between Two New Oral Nicotine Replacement Therapy Products and Nicorette® Microtab

Tobacco Dependence

Sweden
McNeil AB

Completed

Bioequivalence Between a Racecadotril Capsule and Film-Coated Tablet (FCT) to Treat Diarrhea in Adults

Antidiarrheals

Canada
McNeil AB

Completed

Bioequivalence Between an Oral Nicotine Replacement Product and Nicorette® Gum

Tobacco Dependence

Sweden
McNeil AB

Completed

A Study to Test Bioequivalence Between One Test Formulation of Ibuprofen and Two Reference Treatments

Pain

Canada
McNeil AB

Completed

Bioequivalence Between Two Oral Nicotine Sublingual Tablets, 2 mg and 4 mg

Tobacco Dependence

Sweden
McNeil AB

Completed

To Test Bioequivalence Between Two Formulations of Paracetamol/Phenylephrine

Respiratory Tract Infections

Ireland

3

Subscribe